Peripheral circulating, tumor-adjacent PMNs and TANs expressed similarly low levels of proangiogenic VEGF and IL-17A in early and advanced disease (Supplemental Figure 6, C, D, I, and J). This evidence concerns the gene VEGFA and neoplasm.